ITEL TELECOMUNICAZIONI SRL
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Private
- Established
- 1982-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.itelte.it
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7
Phase 3
Active, not recruiting
- Conditions
- RadiotherapyProstate CancerPSMA PETProstatectomyTumor of Prostate18F- Fluorocholine
- Interventions
- Drug: Radiopharmaceutical 18F-JK-PSMA-7Drug: Radiopharmaceutical 18F-Fluorocholine
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- ITEL Telecomunicazioni Srl
- Target Recruit Count
- 106
- Registration Number
- NCT05622162
- Locations
- 🇮🇹
I.R.S.T. Srl Irccs, Meldola, Forlì-Cesena, Italy
🇮🇹Ospedale Classificato Sacro Cuore - Don Calabria, Negrar, Verona, Italy
News
No news found